Global HLA Typing For Transplant Market Overview
HLA typing for transplant market accounted for US$ 637.9 Million in 2020 and is estimated to be US$ 1380.6 Million by 2029 and is anticipated to register a CAGR of 9.0%.
The HLA (Human leukocyte antigen) typing is the technique used to coordinate between donors and patients for the transplants of cord blood or the bone marrow. The HLA is the marker or protein present on number of cells in the body. The framework of immune system uses the markers to identify the cells associating in the body & which don't. So the process is useful before the procedure of organ transplantation. Thus, the HLA typing for transplant market is expected to grow and has tremendous scope over the forecast period. HLA typing for transplant market is expected to flourish in the coming years by rising at a significantly higher CAGR.
Global HLA Typing For Transplant Market Dynamics
Growth in the number of transplantation procedures may enhance the market
Human leukocyte antigen (HLA) typing procedure is used to determine how closely tissue of donor matches with the tissue of recipient before transplantation. Human leukocyte antigens are proteins which inherited from the parents. Immune system utilizes HLA markers in order to recognize the location of cells inside the body and identify which cells belong to body and which do not. HLA matching helps in development and growth of new healthy blood cells and also reduces the risk of post-transplant complication.
However, high cost of devices and limited number of medical center for organ transplantation and donation procedures may restrict the target market growth. Further, stringent policies and norms might also limit growth of the global market to a certain extent.
Global HLA Typing For Transplant Market Segmentation
HLA typing for transplant market is segmented based on technology, product & services, application, end-user, and region.
On the basis of technology, the HLA typing for transplant market is segmented into molecular assay technologies (PCR-based molecular assays and sequencing-based molecular assays) and non-molecular assay technologies. Based on product & services, the target market is segmented into reagents & consumables, instruments, and software & services. Based on application, the target market is segmented into diagnostic applications (antibody screening, chimerism monitoring, and others) and research applications. Based on end-user, the target market is segmented into independent reference laboratories, hospitals & transplant centers, and research laboratories & academic institutes.
Regional Insights:
On region the HLA typing for transplant market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Technologically developed nations in North America such as the U.S. and Canada estimates for the highest share of the global market due to growth in prevalence of chronic diseases such as cardiac, cancer, and renal associated diseases. However, growth in access and high utilization of advanced diagnostic technologies, technological advancements associated with HLA-based transplant diagnostics, and high growth have been registered in developing markets in Asia Pacific. Further, increase in awareness, high population growth, and rise in investments in health care infrastructure demand for HLA typing transplant diagnostics services in Asia Pacific.
Report Scope:
|
Attribute |
Details |
|
Base year for estimation |
2020 |
|
Forecast period |
2020 – 2029 |
|
Market representation |
Revenue in USD Million & CAGR from 2020 – 2029 |
|
Market Segmentation |
By Technology - Molecular Assay Technologies (PCR-Based Molecular Assays and Sequencing-based Molecular Assays) and Non-molecular Assay Technologies By Product & services- Reagents & Consumables, Instruments, and Software & Services By Application– Diagnostic Applications (Antibody Screening, Chimerism Monitoring, and Others) and Research Applications By End-user– Independent Reference Laboratories, Hospitals & Transplant Centers, and Research Laboratories & Academic Institutes |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest application trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the HLA Typing for Transplant market report based on technology, product & services, application, end-user, and region.
HLA Typing for Transplant Market, By Technology:
- Molecular Assay Technologies
- PCR-Based Molecular Assays
- Real-time PCR
- Sequence-specific Primer-PCR
- Sequence-specific Oligonucleotide-PCR
- Other PCR-based Molecular Assays
- Sequencing-based Molecular Assays
- Sanger Sequencing
- Next-generation Sequencing
- Other Sequencing-based Molecular Assays
- Non-molecular Assay Technologies
HLA Typing for Transplant Market, By Product & services:
- Reagents & Consumables
- Instruments
- Software & Services
HLA Typing for Transplant Market, By Application:
- Diagnostic Applications
- Antibody Screening
- Chimerism Monitoring
- Others
- Research Applications
HLA Typing for Transplant Market, By End-user:
- Independent Reference Laboratories
- Hospitals & Transplant Centers
- Research Laboratories & Academic Institutes
HLA Typing for Transplant Market, By Region:
- North America
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
-
- U.S.
- Canada
- Middle East & Africa
Global HLA Typing For Transplant Market Key Players
The key players operating the global HLA typing for transplant market includes Thermo Fisher Scientific, Inc., CareDx, Inc., QIAGEN N.V., Illumina , Immucor, Inc., Bio-Rad Laboratories, Inc., F. Hoffman-La Roche Ltd., Hologic, Inc., Luminex (US), and Biofortuna. Market key player’s focuses on product launches & enhancements, agreements, partnerships, and acquisitions in oder to expand their product portfolios and maintain a competitive position in the HLA typing for transplants market. For instance, In July 2017, Thermo Fisher Scientific acquired the Linkage Biosciences. The acquisition would help Thermo Fisher Scientific in increasing the company’s product portfolio by offering HLA-typing kits, HPA-typing kits KIR-typing kits, and expanding its position in HLA market.
Global HLA Typing For Transplant Market Company Profile
- Thermo Fisher Scientific, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- CareDx, Inc.
- QIAGEN N.V.
- Illumina
- Immucor, Inc.
- Bio-Rad Laboratories, Inc.
- F. Hoffman-La Roche Ltd.
- Hologic, Inc.
- Luminex (US)
- Biofortuna
“*” marked represents similar segmentation in other categories in the respective section
Global HLA Typing For Transplant Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Preview
- Executive Summary
- Key Findings—Global Outlook for HLA Typing for Transplant Strategies
- Key Questions this Study will Answer
- Market Snippet, By Technology
- Market Snippet, By Product & Services
- Market Snippet, By Application
- Market Snippet, By End-user
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Market Segmentation, By Technology, 2020 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2029
- Y-o-Y Growth Analysis (%), 2020 – 2029
- Segment Trends
- Molecular Assay Technologies
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- PCR-Based Molecular Assays
- Real-time PCR
- Sequence-specific Primer-PCR
- Sequence-specific Oligonucleotide-PCR
- Other PCR-based Molecular Assays
- Sequencing-based Molecular Assays
- Sanger Sequencing
- Next-generation Sequencing
- Other Sequencing-based Molecular Assays
- PCR-Based Molecular Assays
- Non-molecular Assay Technologies
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Overview
- Market Segmentation, By Product & Services, 2020 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2029
- Y-o-Y Growth Analysis (%), 2020 – 2029
- Segment Trends
- Reagents & Consumables
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Instruments
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Software & Services
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Overview
- Market Segmentation, By Application, 2020 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2029
- Y-o-Y Growth Analysis (%), 2020 – 2029
- Segment Trends
- Diagnostic Applications
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Antibody Screening
- Chimerism Monitoring
- Others
- Research Applications
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Overview
- Market Segmentation, By End-user, 2020 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2029
- Y-o-Y Growth Analysis (%), 2020 – 2029
- Segment Trends
- Independent Reference Laboratories
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Hospitals & Transplant Centers
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Research Laboratories & Academic Institutes
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Overview
- Global Market, By Region, 2020 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2029
- Y-o-Y Growth Analysis (%), 2020 – 2029
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Product & Services, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2029
- Market Size and Forecast (US$ Mn), By End-user, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2029
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Product & Services, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2029
- Market Size and Forecast (US$ Mn), By End-user, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2029
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Product & Services, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2029
- Market Size and Forecast (US$ Mn), By End-user, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2029
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Product & Services, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2029
- Market Size and Forecast (US$ Mn), By End-user, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2029
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Product & Services, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2029
- Market Size and Forecast (US$ Mn), By End-user, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2029
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
-
- Thermo Fisher Scientific, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- CareDx, Inc.
- QIAGEN N.V.
- Illumina
- Immucor, Inc.
- Bio-Rad Laboratories, Inc.
- F. Hoffman-La Roche Ltd.
- Hologic, Inc.
- Luminex (US)
- Biofortuna
- Thermo Fisher Scientific, Inc.
-
- The Last Word
- Future Impact
- About Us
- Contact
FAQs
The global HLA typing for the transplant market is segmented based on technology, product & services, application, end-user, and region.
Growth in the number of transplantation procedures may enhance market growth, thus driving the growth of the global market.
Technologically developed nations in North America such as the U.S. and Canada estimates for the highest share of the global market due to growth in the prevalence of chronic diseases such as cardiac, cancer, and renal associated diseases.
Market key player’s focus on product launches & enhancements, agreements, partnerships, and acquisitions in order to expand their product portfolios and maintain a competitive position in the HLA typing for the transplants market. For instance, In July 2017, Thermo Fisher Scientific acquired the Linkage Biosciences.